Go Deep
NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,823 | -1.1 | 2.56 | 0.05 | 100.64 |
| Oct 2026 | 22,864 | -1.1 | 2.51 | 0.05 | 98.76 |
| Oct 2026 | 23,023 | -1.0 | 2.32 | 0.05 | 91.06 |
| Oct 2026 | 20,545 | -1.0 | 2.42 | 0.05 | 94.82 |
| Oct 2026 | 20,578 | -1.0 | 2.38 | 0.05 | 93.28 |
| Oct 2026 | 20,724 | -0.9 | 2.20 | 0.05 | 86.19 |
| Oct 2026 | 20,585 | -1.0 | 2.37 | 0.05 | 92.50 |
NeuroOne Medical Technologies Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,973,105.0 | 1,862,050.0 | 2,892,635.0 | 2,740,925.0 |
| Net Profit | -2,006,331.0 | -2,382,022.0 | -1,437,890.0 | -1,619,221.0 |
| EPS | -0.2 | -0.3 | -0.2 | — |
NeuroOne Medical Technologies Corporation Revenue & Profit: Last 4 Years
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Revenue | 9,097,692.0 | 3,453,003.0 | 1,952,441.0 | 171,169.0 |
| Net Profit | -3,605,374.0 | -12,318,110.0 | -11,859,491.0 | -9,999,613.0 |
| EPS | -0.5 | -2.8 | -3.9 | -3.8 |
NeuroOne Medical Technologies Corporation Balance Sheet
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Total Assets | 10,785,647.0 | 5,369,940.0 | 8,097,314.0 | 12,822,609.0 |
| Total Liabilities | 3,713,125.0 | 4,547,927.0 | 1,847,910.0 | 3,218,245.0 |
| Total Equity | 7,072,522.0 | 822,013.0 | 6,249,404.0 | 9,604,364.0 |
Owes vs Owns
NeuroOne Medical Technologies Corporation owed $0.39 for every $1 it owned in Jun 2026, up from $0.25 in Sep 2022.
| Period | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.39× | 0.34× | 0.85× | 0.23× | 0.25× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
NeuroOne Medical Technologies Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Sep 2025
Cash & short-term investments 60.9%Receivables 11.7%Inventory 20.6%Fixed assets (tangible) 4.8%Other assets 1.5%
How it's funded — Sep 2025
Short-term debt 1.1%Long-term debt 1.3%Payables 9.4%Other liabilities 22.6%Shareholders' equity 65.6%
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.6 | 1.5 | 5.3 | 11.1 |
| Receivables | 1.3 | 0.2 | 0.0 | 0.0 |
| Inventory | 2.2 | 2.6 | 1.7 | 0.7 |
| Fixed assets (tangible) | 0.5 | 0.7 | 0.7 | 0.5 |
| Intangible assets | 0.0 | 0.1 | 0.1 | 0.1 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.2 | 0.4 | 0.3 | 0.3 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-term debt | 0.1 | 0.2 | 0.1 | 0.1 |
| Payables | 1.0 | 1.0 | 0.7 | 0.9 |
| Other liabilities | 2.4 | 3.3 | 1.0 | 2.1 |
| Shareholders' equity | 7.1 | 0.8 | 6.2 | 9.6 |
| Net tangible assets | 7.0 | 0.8 | 6.2 | 9.5 |
NeuroOne Medical Technologies Corporation Cash Flow
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Operating Activities | -2,837,272.0 | -11,011,840.0 | -12,886,874.0 | -7,519,534.0 |
| Investing Activities | -81,742.0 | -120,197.0 | 2,649,964.0 | -3,244,765.0 |
| Financing Activities | 8,029,354.0 | 7,269,586.0 | 7,399,074.0 | 12,023,282.0 |